Gliosis is a hallmark of prion disease. A neurotoxic prion peptide (PrP106-126) induces astrocyte proliferation in the presence of microglia. This peptide also directly enhances microglial proliferation in culture. We have investigated this further to understand the method by which factors released by microglia and PrP106-126 work together to enhance astrocyte proliferation. PrP106-126 in the presence of microglia specifically enhanced type 1 astrocyte proliferation but not Type 2. Astrocytes that do not express the prion protein were more sensitive to oxidative stress and the toxicity of cytosine arabinoside. In the presence of cytosine arabinoside, PrP106-126 was toxic to pure astrocyte cultures. Using conditioned medium from microglia we have shown that PrP c -expressing astrocytes proliferate in response to factors released by microglia stimulated by granulocyte/macrophage colony-stimulating factor. This response is enhanced in the presence of PrP106-126. PrP c -deficient astrocytes do not show this response. These results suggest that astrocytes are primed by PrP106-126 to respond more to factors released by proliferating microglia. Astrocytes may proliferate in this system to escape entering the cell suicide pathway.
INTRODUCTION
Prion diseases, which include both CreutzfeldtJakob and Gerstmann-Sträussler-Scheinker syndrome in humans and the animals diseases scrapie and bovine spongiform encephalopathy, are characterized by deleterious changes in the central nervous system including neuronal degeneration, vacuolation, and gliosis (Prusiner, 1991) . Associated with these diseases is the conversion of a normal cellular glycoprotein to an abnormal isoform (Bolton et al., 1982) which shows greater protease resistance and accumulates in affected individuals often in the form of extracellular plaques (Prusiner & DeArmond, 1994) . This protein is termed the prion protein (PrP) and the altered isoform (PrP Sc ) is also the major candidate for the infectious agent in transmissible diseases such as scrapie (Prusiner, 1991; DeArmond & Prusiner, 1993) .
The normal cellular isoform is expressed in neurons (Kretzschmar et al., 1986) and glia (Moser et al., 1995) . The function of normal cellular PrP is still unknown; however, there are reports that suggest it may function at the synapse (Collinge et al., 1994) or that it might aid cellular resistance to oxidative stress (Brown et al., 1997a) . Cells devoid of PrP c expression show a greater susceptibility to toxicity from oxygen radicals, and both cells in culture and adult mice devoid of PrP c expression show reduced activity of an anti-oxidant enzyme, Cu/Zn superoxide dismutase (Brown et al., 1997a) .
Replication of the infectious isoform of PrP requires its expression in infected host cells as mice devoid of cellular expression (Prnp o/o mice) are unable to propagate the infective agent (Bü eler et al., 1992 (Bü eler et al., , 1993 . Although there is evidence of an intracellular production (Borchelt et al., 1992) , at present it is unknown what cells in the central nervous system are respon-
